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ABSTRACT 
Suppression of the effects of an spt10 mutation on 
ADH2 expression is a phenotype shared by a small 
number of genes whose protein products are either 
components of the CCR4-NOT complex required for 
mRNA deadenylation and degradation (CCR4, CAF1, 
NOT4) or have been shown to interact with the com- 
plex (DBF2, SRB9, SRB10). In this work, we con- 
ducted a screen for additional suppressors of spt10 at 
ADH2 to identify new factors related to CCR4 func- 
tion. In addition to reisolating ccr4 and caf1 alleles, 
three previously unidentified suppressors of spt10 
were obtained: ebs1, lsm6, and nup159. These three 
genes are known or presumed to affect mRNA export 
or degradation. Mutations in EBS1, LSM6 and NUP- 
159 not only suppressed spt10-induced ADH2 expres- 
sion but also, like ccr4 and caf1 defects, reduced the 
ability of ADH2 to derepress. None of these defects 
affected the expression of CCR4-NOT complex com- 
ponents or the formation of the CCR4-NOT complex. 
The reduced ADH2 expression was also not the result 
of increased degradation of ADH2 mRNA, as the lsm6 
and nup159 alleles, like that of a ccr4 deletion, actually 
slowed ADH2 degradation. Our results indicate that 
alterations in factors that slow mRNA degradation or 
affect mRNA transport may also interfere with the 
synthesis of mRNA and suggest an integration of such 
events in gene expression.  
 
Keywords: CCR4-NOT Complex; Transcription; 
mRNA Degradation; mRNA Export 
1. INTRODUCTION 
The CCR4 protein is involved in several processes con- 
trolling the metabolism of mRNA in the cell: mRNA 
initiation, elongation, and degradation. CCR4 was origi- 
nally identified as a mutation that suppressed the in- 
creased ADH2 expression on glucose caused by a spt10 
allele, cre1-1 [1]. SPT10 is known to function in part by 
controlling histone gene expression, which in turn can 
alter chromatin structure and gene expression at sensitive 
loci [2]. The interaction of CCR4 with SPT10 is not li- 
mited to the ADH2 promoter, as ccr4 also suppressed 
spt10 at the his4-912 locus [3]. CCR4 is also required 
for maximal expression of ADH2 and other nonfermen-
tative genes [1] and appears involved in other processes 
such as cell wall integrity, amino acid metabolism, cell 
cycle progression, and DNA repair [4-8]. The effects of 
CCR4 at ADH2 and presumably many of these other 
processes occur at the transcriptional level implicating 
CCR4 in the control of mRNA initiation.  
CCR4 functions in the context of two CCR4-NOT 
complexes, 1.0 and 1.9 MDa in size. The 1.0 MDa com- 
plex contains CCR4, CAF1, the five NOT proteins (NOT1- 
NOT5) and three other proteins, CAF40, CAF130 and 
BTT1 [6,9,10]. In addition to CCR4, mutations in both 
CAF1 and NOT4 suppress the effects of an spt10 muta- 
tion at ADH2 and affect the derepression of ADH2, sug- 
gesting that they also are involved in the activation of 
transcription [6,11].  
The NOT1-5 proteins, however, are clearly involved 
in the repression of transcription [12,13], initially identi- 
fied by their binding and restricting TFIID access to non- 
canonical TATAA sequences [14]. In addition, the CCR4- 
NOT proteins have been suggested to play a role in 
mRNA elongation [15]. Recent studies indicate that the 
CCR4-NOT complex is responsible for restarting tran- 
scription after transcriptional arrest has occurred [16]. 
One defined biochemical function for CCR4 is that it 
is the catalytic component of the cytoplasmic deade- 
nylase complex [18-20]. CCR4 mRNA poly (A) deade- 
nylation is the first step in targeting the mRNA for deg- 
radation and caf1 or not4 defects also lead to defects in 
deadenylation [19,20]. A ccr4 defect, therefore, in stabi- 
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lizing mRNA would augment mRNA levels. This effect 
would be opposite in nature to the ccr4 suppression of 
spt10 effects at ADH2 or the requirement of CCR4 for 
ADH2 and other genes’ syntheses. The CCR4 effect on 
ADH2 RNA accumulation implies that it operates by 
mechanisms other than or in addition to controlling 
mRNA degradation.  
To gain further insight into the mechanisms of how 
CCR4 activates gene expression, we have reconducted 
the screen for factors that can suppress spt10-enhanced 
expression at ADH2. The only known suppressors of 
spt10 effects are defects in the CCR4, CAF1 and NOT4 
proteins, all components of the CCR4-NOT complex, 
and the DBF2, SRB9 and SRB10 proteins, which are 
known to associate with the CCR4-NOT complexes [5, 
21]. The SRB9 and SRB10 proteins have been shown to 
be part of mediator, the transcriptional activator complex 
[21,22]. Hence, the ability to suppress spt10-enchanced 
ADH2 expression reflects a common factor related to 
CCR4 function, and possibly to a role not directly in- 
volving effects on mRNA degradation. Utilizing this 
screen for suppressors of spt10, we have identified three 
new genes which when mutated are capable of suppress- 
ing spt10: NUP159, LSM6 and EBS1. These three factors, 
like CCR4, CAF1 and NOT4 are known or presumed to 
be involved in controlling mRNA export or degradation. 
These results suggest that defects in factors involved in 
post-transcriptional regulation of mRNA metabolism may 
result in corresponding decreases in transcriptional ini- 
tiation. The CCR4 requirement at ADH2 may, therefore, 
result from indirect effects involving the integration of 
mRNA synthesis with the subsequent nuclear export and 
degradation of mRNA. 
2. MATERIALS AND METHODS  
2.1. Yeast Strains and Growth Medium  
Yeast strains are listed in Table 1. Strains were grown on 
YEP medium (1% yeast extract/2% Bacto-peptone) sup- 
plemented with 2% glucose and 2% agar (YD plates). 
Allyl alcohol was added to YD plates in the concentration 
indicated in the test. ADH assays were conducted as 
previously described [6]. 
2.2. Analysis of spt10 Suppressors  
Standard genetic techniques were used to identify com- 
plementation groups. Yeast transformations were con- 
ducted with either an YCp50-LEU2, YEpl3, or YEp24 
based genomic library. Western analysis was conducted 
as described [6] using antibody specific to CCR4-NOT 
protein components [23].  
2.3. RNA Analysis 
S1 nuclease protection assays were conducted to quanti- 
tate ADH2 mRNA levels as described [17,24]. The rates 
of ADH2 mRNA half-lives were determined following 
growth of yeast on YEP medium containing 2% glycerol/ 
2% ethanol and shifting to YEP medium containing 8% 
glucose as previously indicated [17].  
 
Table 1. Yeast strains. 
Strain Genotype 
553-4b MATa adh1-11 adh3 cre1-1 ural leu2 trp1 
553-4b-10 MATa adh1-11 adh3 cre1-1 ccr4-10 ural leu2 trp1 
43-2B MAT adh1-11 adh3 ural his4 
43-2B-M1 MAT adh1-11 adh2-1 adh3 ural his4 
1076-2c MAT ura3 his3 leu2 trp1 ccr4::URA3 
1005-2-3c MATa adh1-11 his3 ura3 trp1 leu2 caf1::LEU2 spt10::trp1 
1005-2-3c-s MAT adh1-11 his3 ura3 trp1 leu2 caf1::LEU2 spt10::trp1 
BA1-1 MAT adh1-11 leu2 asg1-4-6 
BA2-1 MAT adh1-11 leu2 his4 ebs1-1-42 
BA3-1 MAT adh1-11 leu2 lsm6-5-17 
BA4-1 MAT adh1-11 leu2 trp1 asg4-4-33 
BA5-1 MAT adh1-11 leu2 trp1 asg5-5-37 
BA6-1 MAT adh1-11 trp1 nup159-6-72 
994-2 MAT adh1-11 his3 ura3 leu2 spt10::TRP1 
994-2-EBS1 MAT adh1-11 his3 ura3 leu2 spt10::TRP1 ebs1::URA3 
LGY101 MAT rat7-1 his3200 ura3-52 leu21 
AEMY19 MAT trp11 his3200 ura3-1 leu2-3,-112 lsm6::URA3        
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3. RESULTS  
3.1. A Screen for Suppressors of spt10 at ADH2 
In order to identify other factors that are functionally 
related to the CCR4-NOT proteins, we conducted a 
search for additional suppressors of the spt10 effects at 
the ADH2 locus using a strain carrying the defective 
adh1-1 allele. The increased expression of ADH2 caused 
by spt10 results in an inability of strains to grow in the 
presence of ally1 alcohol. Ally1 alcohol can be converted 
by ADH enzymes to acrolein that kills the cells. While 
ccr4 alleles were previously identified by such a screen 
[1], in order to identify new suppressors we used a modi- 
fied selection process. In the previous screen, mutations 
that allowed growth on ally1 alcohol-containing plates 
were then tested for sensitivity to the respiratory inhibi- 
tor Antimycin A; complete loss of both ADH I and ADH 
II enzyme activity in the cell would require the utilize- 
tion of oxidative phosphorylation rendering such cells 
Antimycin A sensitive. This secondary requirement re- 
sulted in the elimination of nearly 90% of the ally1 al- 
cohol revertants [1]. Since there is a narrow range of 
ADH enzyme activities that allows growth on both ally1 
alcohol and resistance to antimycin A we were intent on 
identifying new suppressors of spt10 that resulted in 
ADH II activity that fell into this range.  
Strain 553-4b, containing a spt10 mutant allele called 
cre1-1, was chosen for this screen since the cre1-1 allele, 
unlike an spt10 deletion, does not result in phenotypes 
typically associated with ccr4 or not defects: these phe- 
notypes include temperature sensitivity, slow growth, 
and sensitivity to caffeine. Approximately 1 × 108 cells 
of strain 553-4b were spread onto YD plates containing 
10 mM ally1 alcohol. 198 ally1 alcohol resistant colonies 
were selected for analysis. Complementation analysis, 
following mating each of these revertants to strain 43- 
2B-M1 carrying a defective adh2 allele, identified 99 of 
these revertants as containing mutations in the ADH2 
gene (data not shown). 
Since ccr4 and defects in other CCR4-NOT complex 
components are sensitive to caffeine and a number of 
other factors such as high temperature and elevated salt 
concentration, the remaining 99 revertants were tested 
for sensitivity to these conditions. Sixteen of the 99 
showed sensitivity to one or more of the following con- 
ditions: 8 mM caffeine, 37˚C, 16˚C, 0.75 M MgCl2, or 
0.2 M LiC1 (Table 2; data not shown) and were chosen 
for further analysis. 
3.2. Identification of Known Suppressors of 
spt10 
To test if any of these 16 revertants generated in this 
screen were ccr4 mutations, Western analysis was con- 
ducted on each strain to determine if the CCR4 protein 
was absent. Extracts from only one revertant, 553-4b-1- 
65, lacked detectable CCR4 protein (data not shown; see 
also Figure 1). In addition, genetic complementation 
analysis was conducted by crossing a ccr4-containing 
strain to all the revertants. In this case, only revertant 
553-4b-1-65 failed to complement a ccr4 allele. Simi- 
larly, a caf1 strain, 1005-2-3c-s, was crossed to all rever- 
tants to identify those that contained caf1 mutations. Re-  
Table 2. Phenotypic characterization of spt10 revertants. 
Strain Allele 8 mM Caff YD 37˚ 0.2 M LiCl
553-4b-10 ccr4-10 – w/+ – 
1-65 ccr4-1-65 – w/– – 
4-26 caf1-4-26 – – – 
1-42 ebs1-1-42/asg2 + – – 
5-17 lsm6-5-17/asg3 – – + 
6-72 nup159-6-72/asg6 – + + 
4-6 asg1-4-6 – + + 
1-36 asg1-1-36 – + + 
1-52 asg1-1-52 – + + 
1-53 asg1-1-53 – + + 
1-58 asg1-1-58 – + + 
4-11 asg1-4-11 – + + 
5-15 asg1-5-15 – + + 
5-21 asg1-5-21 – + + 
5-84 asg1-5-84 – + + 
6-16 asg1-6-16 – + + 
4-33 asg1-4-33 – + + 
Yeast strains were grown on YEP medium containing 2% glucose supple- 
mented with 8 mM caffeine (8 mM caff) or 0.2 M LiC1. Growth was at 
30˚C except as indicated. “+”: very good growth; “w/+”: good growth; 
“w/–”: poor growth; “–”: no growth. 
 
Figure 1. nup159, lsm6 and ebs1 alleles do 
not affect the expression of CCR4-NOT com- 
ponents. Western analysis was conducted on 
yeast extracts with antibodies directed against 
CCR4, CAF1, NOT4, and CAF40. Left lane- 
(wt) strain 553-4b; other lanes-strain 553-4b 
except containing the allele as indicated. 
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vertants 553-4b-4-26 and -6-72 partially failed to com- 
plement the caf1 mutation, although not completely, so 
that we were unable to conclusively identify these rever- 
tants as containing caf1 mutations. To clarify this result, 
the mutation in revertant 553-4b-4-26 was cloned by 
complementation using a genomic library and the com- 
plementing gene was shown to contain the complete 
CAF1 gene following DNA sequence analysis. Subse- 
quent retransformation of the CAF1 containing genomic 
clone into revertant 553-4b-6-72 failed to complement its 
defects, demonstrating that 553-4b-4-26 is the only caf1 
mutation produced by this screen. Crosses with strains 
containing either a dbf2 or not4 mutation showed that 
none of the remaining revertants carried mutations in 
either of these genes.  
Additional complementation analysis grouped the re- 
maining 14 revertants that displayed pleiotropic effects 
into four complementation groups (Table 2). Most of the 
complementation groups were represented by a single 
revertant, whereas complementation group designated 
asg1 contained 10 members.  
ADH II enzyme activity assays were conducted on the 
16 revertants from each of these complementation groups, 
the parent strain 553-4b, and 553-4b-10, which contains 
the previously characterized ccr4-10 allele (Table 3). 
The ADH II assay values that were obtained confirm that 
growth on ally1 alcohol was due to reduced expression 
of ADH2. As expected, values for many of the revertants 
were not as low as the ccr4-containing strain 553-4b-10 
since many of the revertants identified were not Antimy- 
cin A sensitive (data not shown). On glucose, most rever-  
Table 3. ADH2 expression in spt10 revertants. 
Allele ADH II enzyme activity ADH2 mRNA 
 Glc EtOH Glc EtOH 
wt 52 2400 1.0 1.0 
ccr4-10 16 620 0.32 ND 
ccr4-1-65 22 730 ND ND 
caf1-4-26 19 250 0.12 0.39 
ebs1-1-42 27 1700 0.59 0.64 
lsm6-5-17 15 1400 0.50 0.38 
nup159-6-72 26 240 0.41 0.49 
asg1-4-6 24 570 0.41 ND 
asg1-4-33 43 940 ND ND 
ADH II enzyme activities were conducted as described previously following 
growth in YEP medium supplemented with 8% glucose (Glc) or 3% ethanol 
(EtOH) [46]. The standard error of the mean (SEM) for all ADH assays was 
less than 20% and the values represent the average of at least four determi- 
nations. ADH2 mRNA levels were quantitated using an S1 nuclease protec- 
tion assay as described in Figure 2 using ACT1 mRNA levels as a standard. 
The ADH2 mRNA levels were normalized against levels found in the parent 
strain 553-4b which is given a value of 1.0. The SEMs for the ADH2 mRNA 
levels were less than 20% except for lsm6 and caf1 under ethanol growth 
conditions in which the values were 37% and 28%, respectively. 
tants displayed at least a two-fold reduction of ADH II 
activity compared to the parental strain (Table 3). Assay 
values for these revertants grown in ethanol medium 
showed a wide range of values. Most of the activity 
levels in these revertants fell into an intermediate range 
around 1000 mU/mg of ADH II. For the ten alleles of 
asg1 the range of ADH II activities under ethanol condi- 
tions was from 440 to 1200 mU/mg. These results indi- 
cate that the spt10 revertants, like previously identified 
ccr4 and caf1 alleles, suppressed both spt10-induced 
ADH2 expression and the ability of ADH2 to derepress 
under non-fermentative growth conditions. 
3.3. Cloning of ASG2, 3, and 6 
In order to clone the respective genes for the remaining 
unidentified complementation groups, a representative 
from each group was transformed with either or both low 
and high copy yeast genome libraries. Depending on the 
phenotype of the representative mutant, selection for 
complementing plasmids was conducted on different me- 
dia. Repeated attempts to complement asg1 failed, how- 
ever, and complementing clones were only obtained for 
asg2, asg3 and asg6.  
For strain 553-4b-6-72 (asg6), complementing plas- 
mids were selected on 8 mM caffeine plates. A single 
plasmid (6-72-1), derived from a YCp50-LEU2 genomic 
library, was identified and was shown to contain an 8.4 
Kbp fragment of Chromosome IX. Three genes were 
identified on this plasmid that could potentially be 
responsible for complementing 553-4b-6-72: YIL113w, 
POR2 and NUP159. Given the function of NUP159 as 
involved in mRNA transport out of the nucleus and that a 
defect in such a gene could result in lowered gene 
expression, a nup159 strain (LGY101) was obtained carry- 
ing the rat7-1 mutation (RAT7 is the same as NUP159). 
Crossing strain LGY101 to strain 553-4b-6-72, resulted 
in diploids that failed to grow on 8 mM caffeine plates, 
indicating that the asg6-6-72 mutation could not comple- 
ment the rat7-1 mutation. asg6-6-72 was therefore desig- 
nated as an allele of NUP159. The NUP159 protein has 
recently been shown to play an important role in mRNA 
transport by aiding DBP5 remodeling of the mRNP 
complex [25], but otherwise has no direct role in mRNA 
expression. 
Revertant 553-4b-5-17 (asg3) when transformed with 
the yeast genomic library YEp13 yielded one transfor- 
mant that was caffeine resistant and that was also unable 
to grow on 10 mM ally1 alcohol media. The insert con- 
tained in plasmid 5-17-1 was determined to be a 6.5 Kbp 
fragment of chromosome IV containing three genes, 
ATP17, LSM6 and RGA2. RGA2 has been described as a 
GTPase activating protein, LSM6 is involved in RNA 
splicing processing and mRNA decapping [26,27] and 
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ATP17 is a subunit of ATP synthase. A BamHI-SalI 
fragment of plasmid 5-17-1 that contained ATP17 and 
LSM6 was subcloned into pRS315, a single copy plasmid 
containing a LEU2 gene. This plasmid was able to com- 
plement the caffeine sensitive phenotype of 5-17, show- 
ing that one of these two genes, but not RGA2, was re- 
sponsible for this complementation. Also, following trans- 
formation of a YCp50-LEU2, single copy yeast genomic 
library, into 553-4b-5-17, a single caffeine resistant co- 
lony was obtained that contained a plasmid with both 
ATP17 and LSM6 genes (data not shown). An lsm6- 
containing strain, AEMY19, was crossed to 5-17, and the 
resulting diploid strain failed to grow in the presence of 8 
mM caffeine. This failure to complement indicates that 
the asg3-5-17 mutation is an allele of lsm6. 
Strain 553-4b-1-42 (asg2) after transformation with a 
YEp13 high copy yeast genomic library yielded a single 
plasmid that could complement the ability to grow at 
37˚C and the allyl alcohol phenotype. The insert was 
found to be a 4.3 Kbp region of chromosome IV con- 
taining a single gene, EBS1. EBS1 was initially reported 
to be involved in telomere maintenance based on its se- 
quence similarity to EST1 [28] but more recently it has 
been shown to be the ortholog of the higher eukaryotic 
nonsense-mediated decay protein SMG7 [29]. Its in- 
volvement in nonsense mediated decay may be only one 
means that its is involved in mRNA expression, as it has 
also been demonstrated that EBS1 binds eIF4E, the 
mRNA cap binding protein required for translational 
initiation. In fact, EBS1 is a negative regulator of trans- 
lation [30]. EBS1 also binds DCP1 [31], a component of 
the mRNA decapping complex [20]. Its exact role in 
decapping is not understood, as it does not clearly affect 
mRNA degradation rates (R. Parker, pers. comm), and 
more recent studies indicate that it does not affect MFA2 
decapping [29]. Removal of amino acids 456-783 from 
EBS1, that overlap a putative RNA recognition motif, 
resulted in an EBS1-expressing plasmid that was unable 
to complement the 37˚C growth defect of the 553-4b-1-42, 
demonstrating that the EBS1 gene complemented 553- 
4b-1-42 and that this deleted region is required for EBS1 
function. We also showed that deleting ebs1 gave the 
same phenotype as the ebs1-1-42 allele in that it was 
capable of suppressing an spt10 deletion in its effects on 
either ADH2 or HIS4 (data not shown).  
3.4. spt10 Suppressors Affect ADH2 Expression 
at the Transcriptional Level 
The identification of three additional suppressors of 
spt10 as factors involved in mRNA degradation (LSM6 
and EBS1), translation (EBS1), and transport (NUP159) 
coincide with the role of the other spt10 suppressors, 
CCR4, CAF1 and NOT4, that have known roles in post- 
transcriptional control of mRNA metabolism, including 
that of mRNA degradation, translation, and elongation 
[17-20,32]. We subsequently investigated whether the 
effects of these new spt10 suppressors were the result of 
reducing ADH2 mRNA expression. ADH2 mRNA levels 
were quantitated by S1 analysis and are summarized in 
Table 3 (see also Figure 2, where the zero time points 
are representative assays conducted under ethanol growth 
conditions). Each of the lsm6-17, ebs1-1-42, nup159-6-72 
and asg1-4-6 alleles reduced spt10-enhanced ADH2 
mRNA expression by around two-fold or more under 
glucose growth conditions and by a similar level follow- 
ing ethanol growth conditions. It should be mentioned 
that the spt10 allele does not affect ADH II enzyme le- 
vels following ethanol growth conditions [1,3]. There- 
fore, the effects of these suppressor mutations on ADH II 
activity following non-fermentative growth represent 
direct effects on ADH2 expression. These results indicate 
that these alleles reduce ADH II enzymatic levels by pri- 
marily reducing the steady state levels of ADH2 mRNA 
levels. Therefore, as previously found for CCR4 and 
CAF1 [3,11] (Table 3), these new spt10 suppressors are 
required for activating ADH2 expression. It should be 
noted, however, that under ethanol growth conditions the 
actual steady state reduction in ADH2 mRNA levels by 
lsm6 and nup159 did not appear to directly correlate with 
the degree of reduction in the levels of ADH II enzyme 
activity (Table 3). The cause for this is unclear but could 
result from the unknown nature of the mutation or pos- 
sibly even from pleiotropic effects on the translatability 
or expression of the mRNA.  
3.5. lsm6, ebs1, and nup159 Alleles Do Not Affect 
Expression of CCR4-NOT Complex 
Components 
One likely cause for the suppression of spt10 and of 
ADH2 gene expression by the lsm6, ebs1 and nup159 
alleles is that they reduce the levels of key CCR4-NOT 
complex components. The levels of CCR4-NOT complex 
proteins were subsequently determined by Western ana- 
lysis in strains carrying these mutant alleles. As shown in 
Figure 1, lsm6, ebs1 and nup159 had no effect on the 
relative abundance of CCR4, CAF1, and other complex 
components. We also found that the integrity of the 
CCR4-NOT complex, as evidenced by co-immunopreci- 
pitation, to be unaffected by the lsm6, ebs1, and nup159 
alleles (data not shown). These data indicate that lsm6, 
ebs1, and nu159 affect ADH2 expression by a means 
other than through indirect effects on the CCR4-NOT 
complex. 
3.6. lsm6, ebs1, nup159 Decrease or Have No 
Effect on ADH2 mRNA Half-Lives 
Both LSM6 and EBS1 have known or suggested roles in  
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Figure 2. nup159, lsm6 and ebs1 alleles in- 
crease or have no effect on ADH2 mRNA sta- 
bility. S1 nuclease protection assays were per- 
formed on 40 g of total RNA using an oli- 
gonucleotide specific to the 5’ region of ADH2 
and to ACT1 [17]. ADH2 mRNA stability was 
determined as previously described [17] fol- 
lowing shifting of yeast from ethanol-contain- 
ing medium to glucose-containing medium at 
time zero. The ebs1, nup159 and lsm6 alleles 
are the same as described in Table 2.  
controlling the rate of mRNA degradation, with lsm6 
slowing mRNA decapping and EBS1 interacting with the 
decapping complex or controlling at least nonsense me- 
diated decay [26,27,29]. It was theoretically possible, 
however, that the lsm6 and ebs1 alleles identified in this 
spt10 screen were mutations that enhanced the rate of 
ADH2 mRNA degradation, thereby suppressing spt10 
effects on the initiation of ADH2 synthesis and reducing 
ADH2 expression under non-fermentative growth condi- 
tions. To test this hypothesis we examined the rate of 
ADH2 mRNA degradation in each of these mutated 
strains. ADH2 mRNA half-lives were determined fol- 
lowing pre-growth of yeast under ethanol (non-fermenta- 
tive conditions) and shifting them to glucose growth 
conditions upon which ADH2 syntheses is rapidly shut 
off. Although in an spt10 background there is a low level 
of ADH2 expression under glucose growth conditions, 
this level is much less than found under non-fermentative 
conditions (Table 3 and Figure 2) allowing mRNA half- 
lives to be readily calculated.  
The ADH2 mRNA half-life was found to be about 12 
min in agreement with previous results [17,33]. Both 
lsm6-5-17 and nup159-6-72 slowed ADH2 mRNA degra- 
dation (Figure 2 and summarized in Table 4) while the 
ebs1-1-42 allele had no effect on ADH2 mRNA stability. 
These results indicate that lsm6, nup159, ccr4 [17,33] 
and caf1 (data not shown) all increase the stability of 
ADH2 mRNA. Their effects on reducing the steady state 
levels of ADH2 mRNA must hence even be greater than 
the effects that are summarized in Table 3. Clearly, the 
reduction in ADH2 mRNA levels caused by these alleles 
is not occurring through direct effects on enhancing 
ADH2 mRNA degradation. These results, in contrast, 
suggest that interfering with post-transcriptional processes 
can reduce the level of mRNA synthesis. 
4. DISCUSSION  
CCR4 has been considered an activator of transcription 
since it first was identified as a suppressor of spt10 
effects at ADH2 and as being required for ADH2 dere- 
pression following non-fermentative growth [1,3]. The 
mechanism by which it and other factors related to it, 
such as CAF1 or NOT4, are required for maintaining 
ADH2 mRNA levels has remained, however, obscure [5, 
6,11,21]. The identification of the CCR4-NOT complex 
as involved in mRNA deadenylation, with CCR4 and 
CAF1 as deadenylases [17-20,32,34], indicate that ccr4 
and caf1 deletions actually stabilize ADH2 mRNA and 
hence raise its mRNA levels, not lower them [17,33]. In 
this report we identify three new factors, NUP159, LSM6 
and EBS1, whose defects, like those of caf1 and ccr4, 
suppress spt10-enhanced ADH2 expression and decrease 
the ability of ADH2 to derepress. The known or putative 
roles of NUP159, LSM6, and EBS1 in the post-transcrip- 
tional regulation of mRNA suggests, therefore, a func- 
tional link to CCR4 and CAF1 and a common mechanism 
by which they all affect ADH2 expression. 
The lsm6-5-17, nup159-6-72 and ebs1-1-42 alleles 
effect on ADH2 mRNA levels were not the result of 
increasing the rate of ADH2 mRNA degradation. In fact, 
lsm6 and nup159 stabilized ADH2 mRNA, indicating 
that their effects on the synthesis of the mRNA was at 
least two-fold greater than that observed from monitoring 
ADH2 steady state mRNA levels. Similar conclusions  
Table 4. Effect of spt10 revertants on ADH2 mRNA half-life. 
Allele ADH2 mRNA half-life (min) 
wt 12 ± 0.40 
ebs1-1-42 13 ± 0.90 
lsm6-5-17 29 ± 9.1 
nup159-6-72 26 ± 0.16 
ADH2 mRNA half-lives were calculated as described [17]. ADH2 mRNA 
levels were quantitated by S1 nuclease protection assays. The value ± SEMs 
represent the average of three to five determinations except for lsm6 whose 
value is the average of two determinations. 
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can be made for ccr4 and caf1 defects that caused in- 
creased stabilization of ADH2 mRNA and yet, concur- 
rently, reduced overall ADH2 mRNA levels [3,17,33] 
(Table 3). We also showed that the lsm6, nup159 and 
ebs1 alleles did not alter the abundance of CCR4-NOT 
complex components, indicating that their effects were 
not indirectly through lowering CCR4 and CAF1 abun- 
dance in the cell. In addition, the role of EBS1 in nega- 
tively regulating translation [30] cannot directly explain 
how it would function as an activator of ADH2. 
spt10 results in a low level of ADH2 expression under 
glucose growth conditions by an unknown mechanism 
that could involve affecting ADH2 chromatin structure [2, 
35,36]. The observation that lsm6, nup159, ebs1, ccr4 
and caf1 can each suppress spt10 effects at ADH2 could 
suggest that these factors function downstream of spt10 
on chromatin structure. However, our previous analyses 
indicated that CCR4 acted independently of SPT10 to 
affect ADH2 expression [36]. Also, the fact that lsm6, 
nup159, ebs1, caf1 and ccr4 reduce ADH2 expression 
under ethanol growth conditions when spt10 has no 
effect on ADH2 transcription further supports an effect 
of these alleles on ADH2 independently of spt10.  
One possible model for how CCR4 and CAF1 function 
in activation is that they influence action of the RNA 
polymerase II holoenzyme through their contacts to 
SRB-9, -10, and -11 mediator components [21]. Alterna- 
tively, CCR4 and CAF1 could serve as coactivators by 
somehow mediating the action of activators such as 
ADR1 at ADH2. However, this latter model seems un- 
likely in that ADR1 is not required for spt10-enhanced 
ADH2 expression [1,11].  
Based on the results presented in this paper, we 
suggest a different model for how CCR4, CAF1, LSM6, 
NUP159 and EBS1 act as activators at the ADH2 locus. 
The primary roles for these factors appear to be the 
mRNA degradative process, in mRNA transport from the 
nucleus, or in mRNA elongation. Studies have increas- 
ingly linked transcription initiation processes with post- 
transcriptional processing and transport of mRNA [37]. 
It is, therefore, conceivable that interfering with mRNA 
degradation and transport could result in slower pro- 
cessing and movement of mRNA through the cell. These 
effects could then result indirectly in reducing transcrip- 
tional initiation of particularly sensitive genes. A variant 
of this model would be that proteins involved in post- 
transcriptional mRNA processing are loaded onto the 
mRNA during its synthesis. Defects in these processing 
components would interfere with this loading process 
that again indirectly influences the corresponding initia- 
tion of transcription from certain promoters. In this regard 
CCR4-NOT complex is known to play a critical role in 
mRNA elongation [15,16,38]. Its function as an activator 
of transcriptional elongation would therefore be a very 
direct way for components of this complex to function as 
activators of ADH2 expression. For example, if transcrip- 
tion through the ADH2 gene were particularly prone to 
transcriptional arrests that the CCR4-NOT complex would 
be especially able to bypass by restimulating transcription 
[16], then a positive role for CCR4-NOT proteins would 
be substantiated. But no evidence for ADH2 susceptibility 
to transcriptional arrest is known and the EBS1, NUP159 
and LSM6 factors do not have clear roles in elongation. 
Finally, it has been recently shown that the nuclear 
pore factors may have diverse and direct effects on chro- 
matin structure and hence gene expression [39]. Given 
these interactions between mRNA transport and trans- 
cription, the NUP159 protein and the CCR4-NOT com- 
plex, which has been shown to interact with the mRNA 
export pathway [40], may exert their respective effects 
on ADH2 chromatin structure and expression by virtue of 
their effects on mRNA export. Since the SPT10 protein 
is specifically involved in affecting chromatin structure 
[2,35,36], this could be one means by which defects in 
NUP159 and CCR4-NOT components suppress spt10 
effects. 
In contrast to the above models, given that CCR4, 
CAF1, LSM6, NUP159 and EBS1 defects might be 
expected to have broad affects on the mRNA degradation 
and/or transport of many genes [39-41], it remains pos- 
sible that the mRNA for certain key transcriptional initia- 
tion factors might be specifically sensitive to correspond- 
ing defects in mRNA degradation or transport. For ins- 
tance, the mRNA for holoenzyme or core initiation com- 
ponents might be specifically affected by such defects, 
resulting again, indirectly, in reduced ADH2 gene ex- 
pression. However, whole genome microarray analysis 
with ccr4, caf1 and not4 deletions did not identify 
specific core transcriptional factors under the regulation 
of any of the CCR4-NOT factors [10].  
In that ccr4, caf1, lsm6 and nup159 defects all reduce 
ADH2 steady state mRNA levels and at the same time 
reduce the rate of ADH2 mRNA degradation indicates an 
additional difficulty with interpreting the actual mecha- 
nisms by which factors control gene initiation. A number 
of factors thought to control initiation of transcription 
(HPR1, RTF1, PAF1, SPT5) have been shown to be in- 
volved in post-initiation processes [33,38,42-45]. Whether 
these original effects on transcription initiation were 
merely the consequences of indirect effects derived from 
their post-initiation sites of action has not been deter- 
mined. At least for the case of CCR4-NOT factors 
understanding how their effects on ADH2 mRNA degra- 
dation rates can exert opposite effects on ADH2 synthesis 
may shed new light on the total integration of mRNA 
metabolism. 
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